Adaptive Biotechnologies Corp expected to post a loss of 45  cents a share - Earnings Preview

Adaptive Biotechnologies

03/05/2022 03:04

* Adaptive Biotechnologies Corp  ADPT.OQ   ADPT.O  is
expected
to show a fall in quarterly revenue when it reports  results on
May 4. 
    * The Seattle Washington-based  company is expected to
report  a
1.9% decrease in revenue to $37.71 million from $38.44 million a
year ago, according to the mean estimate from 6 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Adaptive
Biotechnologies
Corp is for a loss of 45 cents per share. For the same quarter
last year, the company reported a loss of 29 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months. ​
    * Wall Street's median 12-month price target for Adaptive
Biotechnologies Corp is $30​, above​ its last closing price
of $8.66. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.47       -0.45      -0.43     Beat    4.7
 Sep. 30 2021  -0.42       -0.42      -0.40     Beat    5
 Jun. 30 2021  -0.42       -0.43      -0.35     Beat    18.1​
 Mar. 31 2021  -0.41       -0.41      -0.29     Beat    29
 ​​Dec.        -0.29       -0.29      -0.33     Missed  -12.7
 31 2020                                                
 Sep. 30 2020  -0.29       -0.28      -0.27     Beat    5​
 Jun. 30 2020  -0.32       -0.28      -0.26     Beat    8.8
 Mar. 31 2020  -0.20       -0.20      -0.25     Missed  -22.2
 This summary was machine generated May 3 at 02:03 GMT.  All
figures in US dollars  unless otherwise stated